Importantly, honokiol could significantly improve the anti-proliferative and anti-invasion activities of erlotinib, a broadly used EGFR inhibitor, and eliminate the resistance to erlotinib of the HNSCC cells. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.